Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study

Introduction: Phosphodiesterase type 5 inhibitors (PDE5i) are first-line therapy for most men with erectile dysfunction (ED). If ineffective, vacuum erection devices, intracavernous injections, and penile prosthesis implantation are suitable as second- or third-line therapies. However, very few pati...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Masato Shirai, MD, PhD, Ippei Hiramatsu, MD, Yusuke Aoki, MD, Hirofumi Shimoyama, MD, PhD, Taiki Mizuno, MD, PhD, Taiji Nozaki, MD, PhD, Shinichiro Fukuhara, MD, PhD, Atsushi Iwasa, MD, PhD, Shinji Kageyama, MD, PhD, Akira Tsujimura, MD, PhD
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Oxford University Press 2018-12-01
Cyfres:	Sexual Medicine
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2050116118300618
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!